Her work invites viewers to confront the scientific realities of our time in a way that is both meaningful and provocatively ...

David H. Holman, Lestin L. Kenton Jr. and Kristina Caggiano Kelly of Sterne, Kessler, Goldstein & Fox PLLC discuss ...

Announced plans for new, state-of-the-art cell therapy R&D facility in Philadelphia Cash and cash equivalents, and time deposits of $1.2 billion, as of September 30, 2024, which Legend Biotech ...

Protect biotech innovation with expert IP strategies in trademark and patent management, featuring insights from Mathys & ...

HONG KONG SAR - Media OutReach Newswire – 12 November 2024 - Immuno Cure BioTech (" Immuno Cure "), a clinical-stage ...

BioSpace takes a look at the headlines across a heavy earnings week for biotechs, checking in on Allogene, Rapport and more.

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

(AFS) announced the expansion of its strategic partnership with KÄÄPÄ Biotech, marked by the opening of a new ...

When I first moved to the San Francisco Bay Area over a decade ago, I remember being overwhelmed with options for places to ...

EigoMANGA is excited to announce its partnership with acclaimed manga creator Takahiro Yonemura to bring readers an original manga series titled "Recycled Brain". This release marks a compelling ...

EigoMANGA announced on Tuesday that it will publish a new original manga by Takahiro Yonemura titled Recycled Brain. Fudeno Saki is illustrating. The publisher will release the first volume, subtitled ...

Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development ...